Selective improvement by rifaximin of changes in the immunophenotype in patients who improve minimal hepatic encephalopathy.
Mangas-Losada A, García-García R, Leone P, Ballester MP, Cabrera-Pastor A, Urios A, Gallego JJ, Martínez-Pretel JJ, Giménez-Garzó C, Revert F, Escudero-García D, Tosca J, Ríos MP, Montón C, Durbán L, Aparicio L, Montoliu C, Felipo V.
Mangas-Losada A, et al.
J Transl Med. 2019 Aug 28;17(1):293. doi: 10.1186/s12967-019-2046-5.
J Transl Med. 2019.
PMID: 31462286
Free PMC article.
Clinical Trial.